Docetaxel and Lidocaine Co-Loaded (NLC-in-Hydrogel) Hybrid System Designed for the Treatment of Melanoma

Melanoma is the most aggressive skin carcinoma and nanotechnology can bring new options for its pharmacological treatment. Nanostructured lipid carriers (NLC) are ideal drug-delivery carriers for hydrophobic drugs, such as the antineoplastic docetaxel (DTX), and hybrid (NLC-in-hydrogel) systems are...

Descripción completa

Detalles Bibliográficos
Autores principales: de Moura, Ludmilla David, Ribeiro, Lígia N. M., de Carvalho, Fabíola V., Rodrigues da Silva, Gustavo H., Lima Fernandes, Priscila C., Brunetto, Sérgio Q., Ramos, Celso D., Velloso, Lício A., de Araújo, Daniele R., de Paula, Eneida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537790/
https://www.ncbi.nlm.nih.gov/pubmed/34683846
http://dx.doi.org/10.3390/pharmaceutics13101552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537790/
https://www.ncbi.nlm.nih.gov/pubmed/34683846
http://dx.doi.org/10.3390/pharmaceutics13101552

Ejemplares similares